May 16, 2024
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
DUBLIN, Ireland (May 16, 2024)…. Trinity Biotech plc (Nasdaq: TRIB) a commercial stage
biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology